Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Evaluation of Oncolytic Viral Therapy Combined with or without Artificial Immunoadjuvant Cell Therapy in Immunocompetent Mouse Tumor Models

Weng-Chit Ung, MSc, Muneyoshi Futami, MD PhD, Kota Sato, MDPhD, Arinobu Tojo, MD PhD

Blood (2018) 132 (Supplement 1): 5793.

https://doi.org/10.1182/blood-2018-99-112789

Published: 2018

Journal Articles

Feasibility of a Cell-Based Oncolytic Virotherapy Targeting Bone Marrow Lesions of Multiple Myeloma

Kota Sato, MD, Muneyoshi Futami, MD PhD, Ung Weng Chit, Takafumi Nakamura, MD PhD, Arinobu Tojo, MD PhD

Blood (2016) 128 (22): 4499.

https://doi.org/10.1182/blood.V128.22.4499.4499

Published: 2016

Journal Articles

Safety, Maximum Tolerated Dose and Immunogenicity of CMV-MVA-Triplex in Healthy Volunteers with or without Prior Immunity to CMV and Vaccinia

Don J. Diamond, PhD, Corinna La Rosa, PhD, Jeffrey Longmate, PhD, Joy Martinez, Qiao Zhou, Theodora Kaltcheva, PhD, Jennifer Drake, Mary Carroll, Sanjeet Dadwal, MD, Ibrahim Aldoss, MD, Ryotaro Nakamura, MD, John A. Zaia, MD

Blood (2015) 126 (23): 3108.

https://doi.org/10.1182/blood.V126.23.3108.3108

Published: 2015

Journal Articles

Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy

Xingbing Wang, PhD MD, Stephen Gottschalk, MD, Xiao-Tong Song, PhD

Blood (2014) 124 (21): 5808.

https://doi.org/10.1182/blood.V124.21.5808.5808

Published: 2014

Journal Articles

Combination Immunotherapy of Advanced Lymphoma with Oncolytic Vaccinia Virus and Checkpoint Inhibitor Following Local Tumor Irradiation

Boris Minev, MD, Holbrook Kohrt, MD, Mehmet Kilinc, PhD, Nanhai Chen, PhD, Audrey Feng, Maysam Pessian, Ulrike Geissinger, Erik Haefner, Desislava Tsoneva, Kliment Bozhilov, Idit Sagiv Barfi, PhD, Xing Zhao, Narendiran Rajasekaran, PhDMSc, Ronald Levy, MD, Aladar Szalay, PhD

Blood (2014) 124 (21): 4487.

https://doi.org/10.1182/blood.V124.21.4487.4487

Published: 2014

Journal Articles

Thymidine Kinase-Deleted, let7a-Regulated Vaccinia Virus Specifically Infects and Lyses Myeloma Cells in a Mouse Myeloma Model

Muneyoshi Futami, MDPhD, Kota Sato, MD, Takafumi Nakamura, PhD, Arinobu Tojo, MD PhD

Blood (2014) 124 (21): 2082.

https://doi.org/10.1182/blood.V124.21.2082.2082

Published: 2014

Journal Articles

Combining Oncolytic Vaccinia Virotherapy with Adoptive T Cell Therapy,

Minhtran Charlotte Ngo, Jun Ando, MD, PhD, Ann M. Leen, PhD, Caroline Breitbach, PhD, Anne Moon, David Kirn, MD, John Bell, PhD, Cliona M. Rooney, PhD

Blood (2011) 118 (21): 4042.

https://doi.org/10.1182/blood.V118.21.4042.4042

Published: 2011

Journal Articles

Activated Platelet-Derived Antimicrobial Peptides Exhibit Virucidal Properties against Vaccinia Virus in Plasma.

Krishna Mohan V. Ketha, Ph.D., Shilpakala Sainath Rao, Ph.D., Chintamani D Atreya, Ph.D.

Blood (2009) 114 (22): 2118.

https://doi.org/10.1182/blood.V114.22.2118.2118

Published: 2009

Journal Articles

Breaking Immune Tolerance to Granule Proteases with Full-Length Antigen Vaccine in Humanized Transgenic Mice Reveals Alternative Antigen Processing and Immunodominance Heirarchy Applicable to Clinical Immunotherapy.

J. Diamond Don, Ph.D, Wendi Zhou, Ph.D, Tumul Srivastava, Ph.D, Ravindra Rawal, Ph.D, Katharine Hagan, Helen A Andersson, Ph.D, J. N. Cooper Laurence, M.D., Jeffrey J. Molldrem, M.D., Simon F. Lacey, PhD, BSc

Blood (2009) 114 (22): 2054.

https://doi.org/10.1182/blood.V114.22.2054.2054

Published: 2009

Journal Articles

The human spleen is a major reservoir for long-lived vaccinia virus–specific memory B cells

Blood (2008) 111 (9): 4653–4659.

https://doi.org/10.1182/blood-2007-11-123844

Published: 2008

Includes: Supplemental data

Journal Articles

Aberrant NK Receptor Signaling Associated with Large Granular Lymphoycte Leukemia and Primary Pulmonary Hypertension.

P.K. Epling-Burnette, PhD, Xianhong Chen, Junmin Zhou, Fanqi Bai, MD, Sokol Lubomir, MD, Edna Ku, MD, Jeffrey S. Painter, BS, Zou JianXiang, MD, Todd D. Edwards, MD, Djeu Y. Julie, PhD, Moscinski C. Lynn, MD, Thomas P. Loughran, MD, Sheng Wei, MD

Blood (2007) 110 (11): 4704.

https://doi.org/10.1182/blood.V110.11.4704.4704

Published: 2007

Journal Articles

Oncolytic Virotherapy for Multiple Myeloma.

Judith Andrea McCart, MD, Hui Deng, Nan Tang, MSc, Gillian Sleep, Navneet Mehta, MSc, Amaalia Stief, Xiu-Zhi Yang, Kimberly Cottick, Colin McKerlie, Suzanne Trudel, MD, Keith Stewart, MD

Blood (2006) 108 (11): 3486.

https://doi.org/10.1182/blood.V108.11.3486.3486

Published: 2006

Journal Articles

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β

Jiangao Zhu, Jennifer Martinez, Xiaopei Huang, Yiping Yang

Blood (2006) 109 (2): 619–625.

https://doi.org/10.1182/blood-2006-06-027136

Published: 2006

Includes: Supplemental data

Journal Articles

Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4 + and CD8 + T-cell responses

Sara Muraro, Attilio Bondanza, Matteo Bellone, Philip D. Greenberg, Chiara Bonini

Blood (2005) 105 (9): 3596–3604.

https://doi.org/10.1182/blood-2004-07-2890

Published: 2005

Journal Articles

Modification of B-CLL Cells Via Infection with a Replication-Defective MVA Virus Encoding Three Costimulatory Molecules: A Potential Approach to Tumor Cell Immunotherapy of B-CLL.

Claudia Palena, Ph.D., Loni McIntosh, Jeffrey Schlom, Ph.D., Kenneth Foon, M.D., Dennis Panicali, Ph.D., Kwong Y. Tsang, Ph.D.

Blood (2004) 104 (11): 2516.

https://doi.org/10.1182/blood.V104.11.2516.2516

Published: 2004

Journal Articles

Novel Conjugates of Epitope Fusion Peptides with CpG ODN Display Enhanced Immunogenicity and HIV Recognition.

Don J. Diamond, PHD, Pirouz Daftarian, PHD, Wahajul Haq, PHD, Rahul Sharan, PHD, Longmate Jeffrey, PHD

Blood (2004) 104 (11): 3856.

https://doi.org/10.1182/blood.V104.11.3856.3856

Published: 2004

Journal Articles

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

Ke-Qin Xin, Yuka Hoshino, Yoshihiko Toda, Shizunobu Igimi, Yoshitsugu Kojima, Nao Jounai, Kenji Ohba, Akira Kushiro, Mayumi Kiwaki, Kenji Hamajima, Dennis Klinman, Kenji Okuda

Blood (2003) 102 (1): 223–228.

https://doi.org/10.1182/blood-2003-01-0110

Published: 2003

Journal Articles

Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus

Marion Subklewe, Ann Chahroudi, Alan Schmaljohn, Michael G. Kurilla, Nina Bhardwaj, Ralph M. Steinman

Blood (1999) 94 (4): 1372–1381.

https://doi.org/10.1182/blood.V94.4.1372

Published: 1999

NARROW

Evaluation of Oncolytic Viral Therapy Combined with or without Artificial Immunoadjuvant Cell Therapy in Immunocompetent Mouse Tumor Models

Feasibility of a Cell-Based Oncolytic Virotherapy Targeting Bone Marrow Lesions of Multiple Myeloma

Safety, Maximum Tolerated Dose and Immunogenicity of CMV-MVA-Triplex in Healthy Volunteers with or without Prior Immunity to CMV and Vaccinia

Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy

Combination Immunotherapy of Advanced Lymphoma with Oncolytic Vaccinia Virus and Checkpoint Inhibitor Following Local Tumor Irradiation

Thymidine Kinase-Deleted, let7a-Regulated Vaccinia Virus Specifically Infects and Lyses Myeloma Cells in a Mouse Myeloma Model

Combining Oncolytic Vaccinia Virotherapy with Adoptive T Cell Therapy,

Activated Platelet-Derived Antimicrobial Peptides Exhibit Virucidal Properties against Vaccinia Virus in Plasma.

Breaking Immune Tolerance to Granule Proteases with Full-Length Antigen Vaccine in Humanized Transgenic Mice Reveals Alternative Antigen Processing and Immunodominance Heirarchy Applicable to Clinical Immunotherapy.

The human spleen is a major reservoir for long-lived vaccinia virus–specific memory B cells

Aberrant NK Receptor Signaling Associated with Large Granular Lymphoycte Leukemia and Primary Pulmonary Hypertension.

Oncolytic Virotherapy for Multiple Myeloma.

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β

Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4 + and CD8 + T-cell responses

Modification of B-CLL Cells Via Infection with a Replication-Defective MVA Virus Encoding Three Costimulatory Molecules: A Potential Approach to Tumor Cell Immunotherapy of B-CLL.

Novel Conjugates of Epitope Fusion Peptides with CpG ODN Display Enhanced Immunogenicity and HIV Recognition.

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only